These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38494931)

  • 21. The role of oxidized low density lipoprotein in atherogenesis.
    Jialal I; Devaraj S
    J Nutr; 1996 Apr; 126(4 Suppl):1053S-7S. PubMed ID: 8642431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractions.
    Tertov VV; Bittolo-Bon G; Sobenin IA; Cazzolato G; Orekhov AN; Avogaro P
    Exp Mol Pathol; 1995 Jun; 62(3):166-72. PubMed ID: 8612720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes.
    Freigang S; Hörkkö S; Miller E; Witztum JL; Palinski W
    Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1972-82. PubMed ID: 9848892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electronegative LDL: An Active Player in Atherogenesis or a By- Product of Atherosclerosis?
    Rivas-Urbina A; Rull A; Ordóñez-Llanos J; Sánchez-Quesada JL
    Curr Med Chem; 2019; 26(9):1665-1679. PubMed ID: 29600751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.
    Palinski W; Hörkkö S; Miller E; Steinbrecher UP; Powell HC; Curtiss LK; Witztum JL
    J Clin Invest; 1996 Aug; 98(3):800-14. PubMed ID: 8698873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.
    Maggi E; Marchesi E; Ravetta V; Martignoni A; Finardi G; Bellomo G
    J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidation of lipoproteins and atherosclerosis.
    Luc G; Fruchart JC
    Am J Clin Nutr; 1991 Jan; 53(1 Suppl):206S-209S. PubMed ID: 1985389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Similarity between naturally occurring modified desialylated, electronegative and aortic low density lipoprotein.
    Tertov VV; Sobenin IA; Orekhov AN
    Free Radic Res; 1996 Oct; 25(4):313-9. PubMed ID: 8889495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies against oxidized LDL--theory and clinical use.
    Steinerová A; Racek J; Stozický F; Zima T; Fialová L; Lapin A
    Physiol Res; 2001; 50(2):131-41. PubMed ID: 11522041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating autoantibodies recognizing peroxidase-oxidized low density lipoprotein. Evidence for new antigenic epitopes formed in vivo independently from lipid peroxidation.
    Seccia M; Albano E; Maggi E; Bellomo G
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):134-40. PubMed ID: 9012648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in Structural Changes and Pathophysiological Effects of Low-Density Lipoprotein Particles upon Accumulation of Acylhydroperoxy Derivatives in Their Outer Phospholipid Monolayer or upon Modification of Apoprotein B-100 by Natural Dicarbonyls.
    Lankin VZ; Tikhaze AK; Konovalova GG
    Biochemistry (Mosc); 2023 Nov; 88(11):1910-1919. PubMed ID: 38105208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
    Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low density lipoprotein-containing circulating immune complexes: role in atherosclerosis and diagnostic value.
    Sobenin IA; Salonen JT; Zhelankin AV; Melnichenko AA; Kaikkonen J; Bobryshev YV; Orekhov AN
    Biomed Res Int; 2014; 2014():205697. PubMed ID: 25054132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis.
    Palinski W; Miller E; Witztum JL
    Proc Natl Acad Sci U S A; 1995 Jan; 92(3):821-5. PubMed ID: 7846059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-density lipoprotein apheresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low density lipoprotein oxidation and atherogenesis: from experimental models to clinical studies.
    Napoli C
    G Ital Cardiol; 1997 Dec; 27(12):1302-14. PubMed ID: 9470066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospects for the Use of Sialidase Inhibitors in Anti-atherosclerotic Therapy.
    Sobenin IA; Markin AM; Glanz VY; Markina YV; Wu WK; Myasoedova VA; Orekhov AN
    Curr Med Chem; 2021 May; 28(12):2438-2450. PubMed ID: 32867633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic AFM detection of the oxidation-induced changes in size, stiffness, and stickiness of low-density lipoprotein.
    Wang K; Li Y; Luo C; Chen Y
    J Nanobiotechnology; 2020 Nov; 18(1):167. PubMed ID: 33183326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients.
    Orekhov AN; Tertov VV; Mukhin DN; Mikhailenko IA
    Biochem Biophys Res Commun; 1989 Jul; 162(1):206-11. PubMed ID: 2751649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of Apolipoprotein B Protein of Circulating Multiple-Modified Low-Density Lipoprotein.
    Zakiev ER; Sukhorukov VN; Ivanova EA; Orekhov AN
    Int J Angiol; 2017 Mar; 26(1):49-52. PubMed ID: 28255216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.